Limited advances in second-line treatments for metastatic ESCC

Advances in esophageal cancer: Current and future strategiesПодробнее

What is the best second-line treatment of advanced renal cell carcinoma (RCC)?Подробнее

Dr. Hugo Ford on Second-Line Docetaxel in Advanced Esophagogastric CancerПодробнее

An overview of treatment advances in gastric cancerПодробнее

Advances in esophageal cancer: Current and future strategiesПодробнее

Second-Line Systemic Treatment of BCCПодробнее

Best agents for 2nd line and treatment of metastatic clear cell renal cell carcinomaПодробнее

Second-Line Treatment of Metastatic Renal Cell CarcinomaПодробнее

Debate 8: Second-line Therapy in Metastatic Upper GI Cancer? - Novel Biologic +/- ChemoПодробнее

Clinical trial for patients with metastatic esophageal cancerПодробнее

Second-Line Angiogenesis Inhibition in Metastatic Renal Cell CarcinomaПодробнее

Second Line Chemotherapy Options for SCLCПодробнее

Treatment of Esophageal Cancer in 2021 | Zev A. Wainberg, MD | Professor of Medicine, UCLAПодробнее

Esophagectomy 🩻 Total Esophageal Removal.Подробнее

ATTRACTION-3: Nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinomaПодробнее

Exploring the latest advances in first-line treatment of ES-SCLCПодробнее

Checkpoint Inhibition in GI Cancers: Recent Advances in Gastric, Esophageal, and CRCПодробнее

Dr. Shah on the Rationale for the KEYNOTE-590 Trial in Esophageal CarcinomaПодробнее

Continuing the momentum in SCLC: Exploring second-line and novel therapy optionsПодробнее